Trial intelligence / Profile preview

Rivastigmine for negative symptoms in chronic psychotic patients

IRCT20250611066174N2Phase 3Completed

Sponsor

Zahedan University of Medical Sciences

Start

Sep 2025

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1